Insulet (PODD) Non-Current Debt (2010 - 2026)
Insulet's (PODD) quarterly Non-Current Debt came in at $929.5 million in Q1 2026, down 42.35% YoY from $1.6 billion in Q1 2025, and little changed on a QoQ basis from $930.8 million in Q4 2025.
Insulet (PODD) Non-Current Debt (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Non-Current Debt data on file, last reported at $929.5 million in Q1 2026.
- Quarterly Non-Current Debt fell 42.35% year-over-year to $929.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $929.5 million (down 42.35% YoY) and the FY2025 annual result came in at $930.8 million, down 28.18% from the prior year.
- Non-Current Debt was little changed at $929.5 million in Q1 2026, from $930.8 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $1.6 billion in Q1 2025 to a low of $929.5 million in Q1 2026.
- A 5-year average of $1.3 billion and a median of $1.4 billion in 2023 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt surged 32.69% — and 2026, when it sank 42.35%.
- Tracing PODD's Non-Current Debt over 5 years: stood at $1.4 billion in 2022, then retreated by 0.57% to $1.4 billion in 2023, then decreased by 5.14% to $1.3 billion in 2024, then slipped by 28.18% to $930.8 million in 2025, then declined by 0.14% to $929.5 million in 2026.
- The last three Non-Current Debt figures came in at $929.5 million (Q1 2026), $930.8 million (Q4 2025), and $934.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Insulet | 10.37 Bn | 9.84 Bn | 562.60 Mn | 929.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 929.50 Mn |
| Mar 31, 2026 | 929.50 Mn |
| Dec 31, 2025 | 930.80 Mn |
| Sep 30, 2025 | 934.90 Mn |
| Jun 30, 2025 | 939.00 Mn |
| Mar 31, 2025 | 1.61 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Sep 30, 2024 | 1.36 Bn |
| Jun 30, 2024 | 1.36 Bn |
| Mar 31, 2024 | 1.36 Bn |
| Dec 31, 2023 | 1.37 Bn |
| Sep 30, 2023 | 1.37 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.40 Bn |
| Dec 31, 2022 | 1.37 Bn |
| Sep 30, 2022 | 1.41 Bn |
| Jun 30, 2022 | 1.39 Bn |
| Mar 31, 2022 | 1.42 Bn |
| Dec 31, 2021 | 1.27 Bn |
| Sep 30, 2021 | 1.26 Bn |